Recombinant Human Semaphorin-4D/SEMA4D Protein(HEK293), hFc

Semaphorin-4D (SEMA4D), a member of the semaphorin family of proteins, plays a critical role in regulating cell signaling, tissue development, and immune responses. Originally identified for its involvement in neural development and axon guidance, recent studies have revealed its significance in various pathological conditions, including cancer, autoimmune diseases, and neurodegenerative disorders. SEMA4D exerts its effects primarily through binding to receptors such as Plexin-B1, leading to diverse cellular responses including cell migration, apoptosis, and immune modulation. The aberrant expression of SEMA4D has been linked to tumor progression and metastasis, positioning it as a potential biomarker and therapeutic target in oncology. The generation of recombinant SEMA4D proteins facilitates in-depth studies of its molecular mechanisms, interactions with other signaling pathways, and effects on immune cell behavior. Researchers are employing these recombinant proteins to explore novel therapeutic strategies that could manipulate SEMA4D signaling for potential clinical applications. Understanding the precise role of SEMA4D in various biological contexts could pave the way for innovative treatments for diseases where SEMA4D is implicated.